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Abbreviations 
2-acetylaminofluorene (2-AAF) 
bone marrow-derived macrophages (BMDM)  
central nervous system (CNS) 
chondroitin sulphate proteoglycan (CSPG) 
damage associated molecular patterns (DAMPs) 
erythroblast macrophage protein (EMP)  
experimental auto encephalitis (EAE)  
extracellular matrix (ECM)  
granulocyte-colony stimulating factor (G-CSF)  
insulin Growth Factor (IGF) 
interferon (IFN)γ  
interleukin (IL) 
lipolysaccharide (LPS) 
liver progenitor cells (LPCs) 
matrix metalloproteinases (MMPs) 
myogenic precursor cell (MPC)  
secretory leukocyte protease inhibitor (SLPI)  
tissue inhibitor of MMP (TIMP) 
TNF-like weak inducer of apoptosis (TWEAK) 
transforming growth factor (TGF) 
tumour necrosis factor (TNF) 
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Abstract 
Macrophages, and more broadly inflammation, have been considered for a long time as bad 
markers of tissue homeostasis. However, if it is indisputable that macrophages are associated with 
many diseases in a deleterious way, new roles have emerged, showing beneficial properties of 
macrophages during tissue repair and regeneration. This discrepancy is likely due to the high 
plasticity of macrophages, which may exhibit a wide range of phenotypes and functions depending 
on their environment. Therefore, regardless of their role in immunity, macrophages play a myriad of 
roles in the maintenance and recovery of tissue homeostasis. They take a major part in the resolution 
of inflammation. They also exert various effects of parenchymal cells, including stem and progenitor 
cell, of which they regulate the fate. In the present review, few examples from various tissues are 
presented to illustrate that, beyond their specific properties in a given tissue, common features have 
been described that sustain a role of macrophages in the recovery and maintenance of tissue 
homeostasis. 
 
Introduction 
Macrophages, first identified – and named – as large phagocytes, play a myriad of roles during 
innate and adaptive immunity. In addition, the last decade has seen the emergence of a multiple 
properties of macrophages, showing that they are more than immune cells (Stefater, III et al., 2011). 
As the presence of macrophages is associated with most diseases, these cells were firstly thought to 
be deleterious, as was thought "inflammation" in the broad sense. However, macrophages are also 
present during the full process of tissue repair and/or regeneration (Murray and Wynn, 2011; Sica 
and Mantovani, 2012). This led to the identification of macrophages as key players in the 
orchestration of the resolution of inflammation and of the restoration of the tissue 
integrity/function. These beneficial effects of macrophages are mainly due to the trophic factors they 
release in the environment, and particularly on parenchymal cells. The wide range of active 
molecules secreted by macrophages likely explains their wide roles in tissue development, repair and 
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homeostasis that have been demonstrated in various tissues (Pollard, 2009). The development of 
techniques and tools including transgenic mouse strains to specifically deplete or trace macrophages 
or macrophage subpopulations, combined to flow cytometry analysis and cell sorting, allowed to 
investigate the diversity of functions of macrophages in several tissues and diseases (Chow et al., 
2011). Moreover, in vitro cocultures performed in parallel to the exploration in vivo led to the 
identification of specific cell interactions macrophages develop with other cells and particularly with 
stem and/or progenitor cells. 
Referring to macrophages, one has to keep in mind that the term "macrophages" encompasses a 
variety of cells harbouring distinct functional phenotypes. Indeed, depending on the environmental 
cues they received, macrophages may adopt various phenotypes and functions (Stout et al., 2005; 
Gratchev et al., 2006). This versatility makes macrophages efficient regulators of tissue homeostasis. 
In an attempt to understand their roles and functions, macrophages have been classified into several 
subpopulations according to their activation (polarisation) state. These populations were defined in 
vitro, under well-defined stimuli and mainly used human monocyte-derived macrophages. Therefore, 
these phenotypes likely not correspond to what occurs in vivo, were concomitant cues may interfere, 
leading to a variety of intermediate phenotypes (review in (Mosser and Edwards, 2008; Mantovani et 
al., 2013)). Classically activated human M1 macrophages (induced in vitro by Interferon (IFN)γ or IFNγ 
plus lipolysaccharide (LPS) or tumour necrosis factor (TNF)α) secrete interleukin (IL)-12, IL-23, 
reactive oxygen and nitrogen intermediates, and inflammatory cytokines (IL-1β, TNFα, IL-6) and 
chemokines (CXCL9, CXCL10). M1 macrophages are associated with the first phases of acute 
inflammation. Mirroring Th1/Th2 immune response, M2 alternative activation state of macrophages 
(triggered by IL-4 and IL-13) was first described. M2 macrophages highly express YM1, arginase 1, 
CCL24 and CCL17 (Gordon and Martinez, 2010; Stein et al., 1992). Then, a series of in vitro stimuli, 
mimicking in vivo cues, has been found to induce an M2-like phenotype. Glucocorticoids, 
transforming growth factor (TGF)β, IL-10 or immune complexes plus LPS or IL-1 trigger M2 
phenotypes. M2 phenotype is characterized by low levels of pro-inflammatory cytokines (IL-1, IL-12), 
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elevated CD206 (mannose receptor), IL-1ra and IL-1 decoy type II receptor, IL-10 expression and 
secretion of CCL17, CCL22, CCL24 chemokines. However, depending on the stimulus which is used to 
polarise the cells, some differences are observed, notably in the capacity to produce inflammatory 
effectors. Other notable differences between M1 and M2 macrophages are related to metabolic 
regulation. M1-polarized macrophages present an anaerobic glycolytic pathway while M2 
polarisation is characterized by oxidative glucose metabolism (fatty acid oxidation), which is believed 
to sustain their long-lasting functions such as tissue remodelling, repair and healing. Iron metabolism 
also differs according to the state of polarisation of macrophages. M1 macrophages store iron 
through high levels of ferritin while M2 cells express high level of ferroportin, the main iron exporter 
(review in (Mantovani et al., 2013; Biswas and Mantovani, 2012; O'Neill and Hardie, 2013; Cairo et 
al., 2011).  
Some attempts have been made to further classify M2 macrophages into subfamilies such as 
M2a, M2b, and M2c, depending on the stimulus used for polarisation (Martinez et al., 2008). 
However these subgroups, defined in vitro in human, only partially overlap with those that were 
described in in vivo murine models, and that were named wounding/healing/resolving macrophages, 
as opposed to classical proinflammatory M1 macrophages. Indeed, M2 macrophages cells take part 
in polarized Th2 responses, parasite clearance, the dampening of inflammation, the promotion of 
tissue remodelling, angiogenesis and tumour progression (Mantovani et al., 2013). 
To add complexity, it has been recently showed that tissue macrophages may come from different 
sources. In the mouse, most of the tissue resident macrophages have an embryonic origin while most 
of the macrophages infiltrating the tissues during inflammation come from blood-derived monocytes 
(Schulz et al., 2012; Hashimoto et al., 2013; Hoeffel et al., 2012). Two main populations of monocytes 
have been described in mouse circulation. Ly6CposCCR2posCX3CR1lo monocytes have a short half-life, 
migrate to inflamed tissues where they produce TNFα, IL-1 and nitric oxide. Ly6CnegCCR2negCX3CR1hi 
cells are found in inflamed and resting tissues and their recruitment depends on the tissue and type 
of injury (Geissmann et al., 2003; Shi and Pamer, 2011). There is no strict matching between Ly6Cpos 
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monocytes and M1 macrophages and between Ly6Cneg monocytes and M2 macrophages. In almost 
all tissues, damage or infection is followed by the rapid entry of LyC6pos monocytes that become M1 
macrophages. In some tissues, Ly6Cneg monocytes have been shown to invade the 
repairing/regenerating tissue after the first Ly6Cpos/M1 wave of infiltration (Auffray et al., 2007; 
Tacke et al., 2007; Nahrendorf et al., 2007; Shechter et al., 2013). In other tissues, at rest or after an 
injury, Ly6Cpos monocytes can give rise to both M1 macrophages, which then switch (or skew) into 
M2 macrophages (Rivollier et al., 2012; Bain et al., 2012; Lin et al., 2009; Arnold et al., 2007). The 
relative contributions of blood-derived macrophages versus tissue resident macrophages during 
tissue repair or chronic inflammation have not been established yet.   
The molecular regulation of macrophage polarisation is starting to be explored. Different 
regulation pathways have recently been associated with either the M1 or the M2 activation states. 
They involve a variety of molecular machineries, at the genomic, transcriptomic and post-
transcriptomic levels (reviewed in (Lawrence and Natoli, 2011)). For instance, NFκB has both pro- and 
anti-inflammatory functions depending on the pathophysiological context. STAT signalling is involved 
in the M1 (STAT1) and M2 (STAT6) polarization (Ohmori and Hamilton, 1997; Takeda et al., 1996; 
Varinou et al., 2003), whereas different Interferon Regulatory Factors (IRFs) are associated with M1 
(IRF5) and M2 (IRF4) gene expression (Krausgruber et al., 2011; Satoh et al., 2010). Several molecular 
systems have been shown to be associated with the expression of the M2 phenotype by 
macrophages, such as PPARs (particularly PPARγ) and the CREB-C/EBP axis (Odegaard et al., 2007; 
Bouhlel et al., 2007; Ruffell et al., 2009; Marigo et al., 2010). At the DNA level, promoters of some 
genes characterising macrophage inflammatory profile are specifically associated with histone 
demethylases or nucleosome remodelling complexes (Lawrence and Natoli, 2011; Satoh et al., 2010). 
Finally, by controlling the stability and translation of mRNAs, post-transcriptional regulons allow the 
coordinated expression of chemokines and cytokines involved in the initiation as well as the 
resolution phases of inflammation (Anderson, 2010).  
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In vascularised tissues, damage is followed by an inflammatory response, which is characterised 
by the presence of M1 macrophages (Chen and Nunez, 2010). This response is necessary for limiting 
the area of tissue damage, for preventing leakage and for cleansing cell/tissue debris. The second 
phase is the tissue repair, or regeneration when the parenchyma is able to recover function. This 
process is possible thanks to the resolution of inflammation, where M2 macrophages play an 
important role. Beside the regulation of inflammation per se, M1 and M2 macrophages have been 
shown to exert specific effects on stem/precursor cells in various tissues. Their role in the 
coordination of the repair/regeneration process and the recovery of tissue homeostasis is emerging. 
In this review, we will present few examples of tissue repair/regeneration after a sterile damage, in 
which macrophages have been shown to play important trophic roles. Although fine tuning of 
repair/regeneration in a given tissue likely requires specific and orchestrated signals, common 
features of the kinetics of macrophage polarisation and properties can be observed in various 
tissues. Macrophages are also involved in the homeostasis of tissues having permanent renewal; an 
example is given as the erythroblastic island. 
 
Liver regeneration 
Kupffer cells are the resident macrophages of the liver, which activate upon liver injury. Both 
Kupffer cells and monocyte-derived macrophages are involved in liver regeneration: macrophage 
depletion leads to a delayed regeneration associated with a decrease in the rate of mature 
hepatocyte proliferation and a down regulation of various pro- and anti-inflammatory cytokines 
(Meijer et al., 2000). In 2005, Duffield et al. showed for the first time the existence of a biphasic 
curve of macrophage activation/function during liver regeneration by ablation of 
monocytes/macrophages at different time points after liver injury (Duffield et al., 2005). To this 
purpose, they used the transgenic mouse CD11b-DTR (receptor for diphteria toxin expressed under 
the control of CD11b promoter) in which monocytes/macrophages can be selectively depleted upon 
diphteria toxin injection (granulocytes and lymphocytes are not targeted by the toxin). During the 
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fibrogenic phase, macrophage depletion results in reduced scarring and fewer myofibroblasts. 
Conversely, during the phase of recovery, macrophage depletion leads to a failure of matrix 
degradation and fibrosis. These data were pioneers in evidencing functionally distinct subpopulations 
of macrophages in the same tissue depending on the phase of tissue remodelling (Duffield et al., 
2005). Under conditions where proliferation of mature hepatocytes is inhibited, liver progenitor cells 
(LPCs), also known as oval cells, expand and differentiate into hepatocytes and biliary epithelial cells 
in order to regenerate liver after damage. Models of LPC expansion (e.g. choline-deficient ethionine-
supplemented diet, 2-acetylaminofluorene (2-AAF) administration combined to partial hepatectomy) 
are characterized by the presence of huge number of macrophages. Several studies have explored 
the trophic functions of macrophages on LPCs, which are always located in close vicinity (Lorenzini et 
al., 2010). Macrophage depletion is associated with an altered LPC fate, although absence of the 
evidence of direct interactions does not allow to conclude whether macrophage effects on LPCs are 
direct or indirect (Thomas et al., 2011). Delivery of bone marrow-derived macrophages (BMDM) in 
injured liver triggers a decrease of myofibroblast number and an expansion of LPCs, which are 
associated with an increase of metalloproteinases (MMPs), of IL-10, and of the LPC mitogen TNF-like 
weak inducer of apoptosis (TWEAK), which is known to be secreted by macrophages (Thomas et al., 
2011). However, macrophage depletion has not been found to directly alter LPC proliferation rate, 
but to reduce their invasiveness into the parenchyma, which is necessary for their differentiation into 
hepatocytes. This effect may be due to either a direct chemotactic effect of macrophages on LPCs or 
an alteration of extracellular matrix (ECM) and of myofibroblasts by macrophages (Van et al., 2011). 
Anyway, macrophage depletion induces a decrease in LPC number and impairment in their 
differentiation and maturation, as almost no formation of small hepatocyte-like cells being observed 
(Xiang et al., 2012). Since LPC proliferation and apoptosis rates are not altered by macrophage 
depletion, this suggests that macrophages are required for the very early phase of LPC priming after 
acute injury to enter the cell cycle (Xiang et al., 2012). This hypothesis was further confirmed by a 
very smart study which deciphers some early signalling pathways the environment, including 
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macrophages, delivers to LPCs to induce them in the hepatocyte route. After a hepatic damage, 
macrophages are induced to secrete Wtn3a upon phagocytosis of liver debris. Macrophage-derived 
Wnt3a triggers the expression of the Notch signalling inhibitor Numb in LPCs to prevent their 
differentiation into biliary cells, while inducing their differentiation in hepatocytes by the activation 
of the Wnt-βcatenin pathway (Boulter et al., 2012). Altogether, these studies show the importance of 
macrophages during liver repair and regeneration. Although the M1/M2 paradigm has not been 
investigated in this context, there is evidence for several functional populations of macrophages in 
the regenerating liver, specifically acting on both hepatocytes and progenitor cells to recover liver 
homeostasis. 
 
Skeletal muscle regeneration 
Contrary to many tissues which repair after an injury, skeletal muscle is capable of fully 
regeneration, with recovery of its function. This is due to the properties of satellite cells, the main 
adult muscle stem cells, which activate after damage and expand before differentiating and fusing to 
form new myofibres (Wang and Rudnicki, 2012). Macrophages have always been observed during 
muscle regeneration. Specific depletion of circulating monocytes with diphteria toxin in the CD11b-
DTR mouse (which spares all types of granulocytes (Duffield et al., 2005)) or with clodronate-
encapsulated liposomes shows a very severe impairment of muscle regeneration (Bryer et al., 2008; 
Summan et al., 2006; Arnold et al., 2007), indicating the crucial involvement of these cells in muscle 
regeneration. The first studies have suggested that macrophages that are present during the first 
phases of muscle regeneration (time of necrosis and phagocytosis of muscle debris) differ from those 
that accompany the late phases of the process (formation and growth of the new myofibres) 
(McLennan, 1993; McLennan, 1996). This sequence was recently confirmed, thanks to new 
immunological tools, together with cell sorting techniques and the use of lineage tracing mouse 
strains. Soon after injury, LyC6posCCR2posCX3CR1lo blood-derived monocytes/macrophages infiltrate 
the injured muscle area. These macrophages switch their phenotype towards a M2 
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resolving/wounding phenotype (Ly6CnegCCR2negCX3CR1hi), likely upon phagocytosis of muscle debris 
(Arnold et al., 2007). Thus skeletal muscle regeneration is characterized by a sequence of M1 then 
M2 macrophages, which has been confirmed during human muscle regeneration (Saclier et al., 
2013b). The phenotype of these populations evolves with time. Soon after injury, a majority of M1 
cells are present, which express higher amounts of TNFα and IL-1β. Then M2 cells appear rapidly, 
expressing higher amounts of IL-10 and TGFβ and these cells predominate during several days. At the 
end of muscle regeneration, not only the number of macrophages decreases but the phenotype of 
both Ly6CposF4/80pos (F4/80 is a macrophagic marker) and LY6CnegF4/80pos cells changes towards a 
dampening of all cytokine markers, suggesting a skewing into M2 resolving/silencing macrophages 
(Perdiguero et al., 2011). Very importantly, perturbing this kinetics strongly alters muscle 
regeneration. Indeed, a too early anti-inflammatory signal (e.g. injection of IL-10 or blocking IFNγ few 
days after injury) as well as blocking later anti-inflammatory signals (injection of anti-IL-10 antibodies 
during the last phase of muscle regeneration) impedes muscle regeneration (Cheng et al., 2008; 
Perdiguero et al., 2011). 
The pioneer studies on macrophages during muscle regeneration suggested various effects of 
macrophage subsets on myogenic cell populations. These have been confirmed through a series of in 
vitro and in vivo analyses. Macrophages stimulate myogenic precursor cell (MPC) chemotaxis, 
growth, and survival through the delivery of anti-apoptotic cues (Saclier et al., 2013b; Sonnet et al., 
2006). In vitro cocultures experiments using M1 and M2 polarised macrophages helped to finely 
analyse their role on MPCs. Pro-inflammatory M1 macrophages stimulate MPC proliferation and 
inhibit their fusion. Conversely, M2 macrophages (both M2a and M2c) stimulate myogenesis by both 
promoting MPC commitment into terminal differentiation and the formation of large myotubes 
(Saclier et al., 2013b). Accordingly, in vivo depletion of intramuscular macrophages during the late 
phase of muscle regeneration leads to a decrease of the size of the newly formed myofibres (Arnold 
et al., 2007), confirming the role of M2 macrophages in differentiation of myogenic precursors. The 
effectors that drive these multiple effects of macrophages on MPCs start to become known (review 
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in (Saclier et al., 2013a)). Anti-apoptotic contacts between macrophages and myogenic cells involves 
at least four cell to cell molecular couples, VCAM-1(CD106)/VLA-4(CD49d), ICAM-1(CD54)/LFA-
1(CD11a), CX3CL1/CX3CR1 and PECAM-1(CD31)/PECAM-1(CD31) (Sonnet et al., 2006). Among 
molecules that stimulate myogenic cell proliferation, IL-6, TNFα, IL1-β, Granulocyte-colony 
stimulating factor (G-CSF) have been shown to be highly secreted by M1 macrophages; M2 
macrophages secrete TGFβ, Insulin Growth Factor (IGF)-1 and low TNFα which stimulate the 
formation of myotubes and promote regeneration (Hara et al., 2011; Lu et al., 2011; Saclier et al., 
2013b).  
Skeletal muscle regeneration is sustained by the sequential presence of first M1, then M2 
macrophages that deliver specific cues to promote expansion, than differentiation of muscle 
progenitors. 
 
Kidney regeneration 
After damage (experimentally, most of the studies uses the ischemia/reperfusion model injury), 
the renal parenchyma can regenerate. It has also been shown that just after injury, resident and 
recruited macrophages may directly damage the tissue through their M1 phenotype (they produce 
oxygen radicals, hydrogen peroxide, nitric oxide, IL-1, TNFα). Therefore, depletion of macrophages 
before or during the first steps after injury improves tissue repair (Nelson et al., 2012; Lee et al., 
2011). In contrast, later phases of injury are associated with M2 macrophages, which depletion is 
associated with persistent kidney injury, increased apoptosis, impaired tubular cell proliferation and 
sustained inflammation (Lee et al., 2011; Kim et al., 2010). In injured kidney, as in skeletal muscle, 
Ly6Cpos bone marrow monocyte population is selectively recruited and gives rise to several 
macrophage populations, among them Ly6Cneg cells that exhibit an M2 phenotype (Lin et al., 2009). 
M2 macrophages (expressing arginase 1 and the mannose receptor) actively promote repair of 
injured renal tubules. They clear damage associated molecular patterns (DAMPs) and other cell and 
matrix debris, they stimulate proliferation of surviving cells through the elaboration of Wnt ligand, 
11 
 
and they promote angiogenesis (review in (Nelson et al., 2012)). During kidney repair, macrophage 
populations follow a biphasic response suggestive of the presence of subpopulations fulfilling 
disparate functions. Functional in vivo studies showed that infusion of IFN-stimulated BMDM 
worsens kidney damage (Lee et al., 2011) while IL-10-transduced macrophages modify the 
inflammatory milieu, induce tubular cell proliferation and protect them from apoptosis (Jung et al., 
2012). IL-4-stimulated (M2) macrophages, but not IFNγ-stimulated ones, promote renal tubular cell 
proliferation (Lee et al., 2011). Molecular effectors involved in these effects are poorly known. 
Macrophage-derived CSF-1 (M-CSF) treatment increases tubular epithelial cell proliferation and 
decreases their apoptosis (Menke et al., 2009). Macrophages also secrete Wnt7b, which has been 
shown to promote regeneration in kidney by directing epithelial cell-cycle progression and basement 
membrane repair. Specific depletion of Wnt7b in macrophages (in Csf1R-iCRE;Wnt7fl/fl mouse) 
induces a delay in regeneration, an increase in the expression of the epithelial cell injury-associated 
marker (injury molecule-1 Kim1), and a blockade of epithelial cell progression into G2/M phase of the 
cell cycle (Lin et al., 2010). Anti-inflammatory (IL-10 stimulated) macrophages protects epithelial cells 
from apoptosis and stimulates their proliferation through the increase of intracellular iron pool and 
the increased expression of lipocalin-2, which is, in an iron-dependent way, a growth and 
differentiation factor (Jung et al., 2012). The biphasic response of macrophages, from M1 to M2 
during kidney regeneration is due to a switch of their phenotype. Tracking IFN-stimulated 
macrophages that have been adoptively transferred into injured recipient shows that these cells can 
switch to an M2 phenotype at the onset of kidney repair (Lee et al., 2011). Taken together, these 
studies show that macrophages undergo a switch from a proinflammatory to a trophic phenotype 
that supports the transition from tubule injury to tubule repair during kidney regeneration. 
 
Nerve regeneration 
In the central nervous system (CNS), first evidence of a role of macrophages came from in vitro 
culture systems in which dorsal root ganglia neurons were cultured in conditioned media from 
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peritoneal macrophages. The presence of macrophages more than doubles the proportion of 
surviving neurons and neurite extensions. When macrophages had phagocytosed a myelin fraction, 
macrophage efficiency is increased. Of interest, LPS-stimulated macrophages do not present this 
trophic effect (Hikawa et al., 1993; Hikawa and Takenaka, 1996). A breakthrough in the 
understanding the supportive role of macrophages in CNS repair has been made by Michal 
Schwartz's team in 1998, in a study that opened the way of a long series of investigations. This study 
shows that transplantation of macrophages - that were previously activated with peripheral sciatic 
nerve debris - in the lesion after complete transection of spinal cord leads to partial functional 
recovery and regrowth and reconnexion of neural fibres. The phagocytic activity of macrophages 
during the in vitro phase of the experiment is crucial for their activation and their subsequent trophic 
activity in vivo (Rapalino et al., 1998). Monocyte-derived macrophages are essential for recovery, as 
demonstrated by adoptive transfer experiments (Shechter et al., 2009). Several experiments indicate 
the sequential presence of M1, then M2 microglial/macrophages at the lesion site, suggesting that, 
as in other tissues, post-injury CNS repair follows a "wound" process (Shechter and Schwartz, 2013; 
Kigerl et al., 2009). A recent study explored the recruitment of blood-derived monocytes after spinal 
cord injury. Only M1 Ly6CposCXRCR1lo monocytes are recruited via the leptomeninges through CCR2 
signalling at the site of the injury (Shechter et al., 2013). At the same time, M2 macrophages are 
recruited from blood at the level of the choroid plexus, which provides a M2 environment. Adoptive 
transfer experiments suggest that here again, only Ly6CposCXRCR1lo monocytes are recruited, but 
through VCAM-1 and CD73, they are rapidly educated into M2 cells. These cells then migrate from 
the choroid plexus through the cerebrospinal fluid to the injury site where they can promote axonal 
growth and tissue repair (Shechter et al., 2013). Some molecular mechanisms have been identified in 
the instruction of macrophagic cells into M2 cells, such as the glial scar matrix chondroitin sulphate 
proteoglycan (CSPG). It promotes IL-10 production by macrophages, which in turn produce MMP-13 
that is essential for functional recovery (Shechter et al., 2011). Similarly, substance P triggers and 
anti-inflammatory milieu in spinal cord injury, which induces IL-10 production by macrophages, and 
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the reduction of inducible nitric oxide synthase and TNFα synthesis (Jiang et al., 2012). In the same 
way, introducing anti-IL-6 antibodies switches macrophages from a haematogenous phenotype to a 
resident-microglial-like phenotype, which is associated with a decrease of pro-inflammatory markers 
and an increase in axonal regeneration and sprouting (Mukaino et al., 2010). Similarly, the 
overexpression or the injection of the anti-inflammatory molecule secretory leukocyte protease 
inhibitor (SLPI) triggers a protective effect after spinal cord injury with an improvement in locomotor 
control, associated with downregulation of the NFκB pathway and of TNFα (Ghasemlou et al., 2010). 
The interactions between macrophages and neural progenitors have also been explored in vivo 
and in vitro. Transplanted neural stem/precursor cells establish contacts with phagocytes and skew 
the inflammatory cell infiltrate by reducing the proportion of M1 macrophages, thus promoting the 
healing of the injured cord (Cusimano et al., 2012). Cocultures of macrophages (OX42pos) and neural 
progenitors (NG2pos) isolated from injured spinal cord showed that macrophages secrete factors 
inhibiting neural progenitor growth (Wu et al., 2010). Indeed, M1 macrophages are neurotoxic or 
block both neurogenesis and oligodendrogenesis of adult neural progenitor cells. Inversely, M2 
macrophages promote a regenerative growth response in adult sensory axons (Kigerl et al., 2009). 
Microglia activated by cytokines stimulates neurogenesis. The IL-4-activated microglia shows a bias 
towards oligodendrogenesis while the low level IFNγ-activated microglia shows a bias towards 
neurogenesis (Butovsky et al., 2006b). These properties were confirmed in in vivo experiments, in 
which injection of IL-4-activated microglia into the cerebrospinal fluid in an Experimental Auto 
Encephalitis (EAE) model results in an increased oligodendrogenesis in the spinal cord, associated 
with improved clinical symptoms (Butovsky et al., 2006a). Nevertheless, the molecular activity of 
macrophages on neural stem cells is poorly known. M1 neurotoxicity is likely due to their secretion of 
several cytokines, among which TNFα (Butovsky et al., 2006b), and thrombospondin-1, tissue 
inhibitor of MMP (TIMP)1 and MMP9, which are also expressed by microglial cells in vivo (Wu et al., 
2010). Beneficial effects of IL-4 activated microglia have been shown to involve IGF1 (Butovsky et al., 
2006a). Ferritin, which is a macrophage-derived signal that promotes oligodendrogenesis, may be 
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also involved in the trophic role of macrophages. Indeed, after transplantation of ferritin-loaded 
macrophages into intact spinal white, proliferating NG2pos neural stem cells migrate into the 
macrophage transplants and accumulate fluorescently labelled ferritin (Schonberg et al., 2012). 
Central nervous system repair is sustained by macrophages that in parallel to their classic 
inflammatory roles, delivery specific cues to neural progenitor cells to ensure both resolution of 
inflammation and tissue repair. 
 
Erythropoiesis – the erythropoietic island 
50 year ago, macrophages have been found associated with maturating erythroblasts in the bone 
marrow, thus forming the erythroblastic island (reviews in (Manwani and Bieker, 2008; Chasis and 
Mohandas, 2008)). They form distinct anatomic structures composed of developing erythroblasts 
surrounding a central macrophage. Usually, islands include one or more synchronously maturing 
cohorts of erythroid cells undergoing four or five divisions between proerythroblast and normoblast 
stages. At the end of terminal differentiation, expelled nuclei of erythrocytes are phagocytosed by 
the central macrophage. Erythroblastic island provides a unique site for erythropoiesis, in which the 
central macrophage plays a crucial supportive role. Disrupting island integrity by disrupting links 
between maturating erythroblasts and macrophage leads to increased erythroblast apoptosis and to 
decreased proliferation, maturation and enucleation. Macrophage provide various interactions, 
including cell:cell binding and secreted factors to finely modulate erythropoiesis and 
erythroblast/cyte number through the control of proliferation, survival, terminal differentiation 
(promotion of enucleation and phagocytosis of extruded nucleus), iron transfer and nutrient supply 
(reviews in (Manwani and Bieker, 2008; Chasis and Mohandas, 2008)). Erythroblast macrophage 
protein (EMP) has been shown, through homophilic interactions, to prevent apoptosis of maturating 
erythroblasts (Hanspal et al., 1998). Later during erythropoiesis, EMP, which plays a role in actin 
organization, is involved in nucleus partitioning and its recognition by engulfing macrophage at the 
time of enucleation, phagocytosis being driven by MFG-E8. α4β1/VCAM1 and ICAM4/αν bindings are 
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also involved in island integrity. A soluble form of ICAM4 is secreted at terminal differentiation and 
may participate to mature erythrocyte detachment from the central macrophage (Lee et al., 2006). 
Iron transfer to maturating erythroblast is believed to occur through the central macrophage, since 
ferritin is localized between the two cell types and macrophages bear ferroportin, responsible of the 
export of iron (Manwani and Bieker, 2008). CD69, CD163 are also involved in the function of the 
erythroblastic island, as well as Ephrin2/EphB4 (in the proliferation of erythroblasts). Moreover, 
several locally secreted molecules positively and negatively regulate erythroblast maturation, such as 
IGF-1 (positive regulation), TGFβ, IL-6, TNFα, IFNγ (negative regulation). Indeed, macrophage may 
exert negative role on erythroblast survival. It has been shown that immature erythroblasts express 
the RCAS1 receptor (receptor binding cancer antigen expressed in Siso cells). Macrophages secrete 
soluble RCAS1, thus activating apoptosis in erythroblasts (Matsushima et al., 2001). This complexity 
of erythropoiesis regulation by macrophages in the island has been very recently highlighted by two 
in vivo studies aiming at specifically depleting macrophages under various conditions. Specific 
depletion of bone marrow macrophages (in the CD169-DTR mouse) triggers both a decrease in the 
number of erythrocytes/erythroblasts in the bone marrow and an increase of their lifespan. As a 
result, mice do not suffer from anaemia (Chow et al., 2013). In pathological conditions, the 
supportive role of macrophages has been clearly evidenced in vitro and in vivo. After an acute 
anaemia, macrophages are essential for recovery and erythrocyte development. Inversely, 
polycythemia, which is characterized by elevated erythropoiesis, is improved by macrophage 
depletion (in the CD169-DTR mouse or with clodronate-liposomes) (Ramos et al., 2013; Chow et al., 
2013). The immune signature of macrophage in the erythroblastic island is very particular. These cells 
are very large (more than 15 µm diameter), do not express Mac1, and do express F4/80 and a series 
of markers, some of them not being usually expressed by macrophages in other tissues: CD16, CD32, 
CD64, CD4, CD31, CD11a, CD11c, CD18, and HLA-DR (Manwani and Bieker, 2008). Further studies will 
indicate whether this signature is altered under different conditions of erythropoiesis homeostasis, 
or upon inflammation.  
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Concluding remarks 
From the recent studies investigating the roles of macrophages after injury in various tissues, 
some common features arise that suggest that post-injury inflammation follows a "wounding" or 
"healing" kinetics with the sequential presence of pro-inflammatory M1 then M2 macrophages. After 
a sterile injury, so in the absence of immune challenge, the M1 pro-inflammatory phase is likely very 
short and resolution of inflammation quickly takes place. Then the proresolving/healing M2 
macrophages sustain tissue repair and/or regeneration (Lucas et al., 2010). The next challenges 
include the deciphering of both the molecular regulation of these macrophages subsets and their 
precise signalling on precursor cells in the tissues. This will be of importance for attempting of 
manipulation of the inflammatory compartment for the improvement of regeneration and of some 
diseases associated with chronic inflammation. In these contexts, both M1 pro-inflammatory and M2 
resolving macrophages coexist and are not more able to promote tissue repair and homeostasis 
recovery. 
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